查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1588303

胃腸道診斷市場規模、佔有率、趨勢分析報告：按測試類型、技術、應用、測試地點、區域、細分市場預測，2025-2030

Gastrointestinal Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Endoscopy, Blood Test), By Technology, By Application, By Test Location, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

胃腸診斷市場成長與趨勢：

根據Grand View Research, Inc.最新報告，預計2030年全球胃腸道診斷市場規模將達65.6億美元，2025年至2030年複合年成長率為4.3%。

人們對胃腸道疾病的認知不斷提高，胃腸道疾病檢測的快速增加是推動市場的主要因素。此外，胃腸道傳染病檢查技術的進步預計將滿足市場需求。例如，2022年5月，QIAGEN推出了QIAstat-Dx Rise，可以在一小時內提供多種疾病的結果。

久坐的生活方式、缺乏體力活動、不健康的飲食習慣和肥胖盛行率的日益成長預計將推動胃腸道診斷市場的成長。據疾病預防控制中心稱，美國的肥胖率為30-40%。阿拉巴馬州、阿拉斯加州和亞利桑那州等州是美國肥胖最嚴重的州之一，肥胖與胃食道逆流、腹瀉和胃癌等胃腸道疾病有關。因此，預計將為市場成長提供動力。

與用於早期診斷和有效測試的胃腸道診斷相關的技術進步預計將在預測期內促進市場成長。例如，2022 年 3 月，Luminex Corporation 的 NxTAGxMAP GI 病原體面板獲得了 CE 標誌。該測試是一項詳細的多重測試，可檢測糞便檢體中 16 種臨床最相關的病毒、寄生蟲和細菌病原體的核酸。此外，該測試可以提供當天結果，並且可以一次測試 96 個檢體。

此外，參與提高胃腸道疾病意識的組織的存在預計將推動市場擴張。例如，胃腸道協會（加拿大腸道研究協會）和國際胃腸道疾病基金會等組織積極參與促進胃腸道健康並增加對胃腸道疾病的了解，正在推動市場成長。

此外，市場參與者為加強產品系列和擴大全球足跡所採取的各種策略舉措可能為市場提供利潤豐厚的成長機會。例如，2021 年 11 月，Liferaft Group 和 Bayer Yakuhin 宣布進行一項合作研究，以擴大胃腸道基質腫瘤患者獲得基因組檢測的機會。此次合作的目標是推進精準醫學並改進基因檢測以識別美國的患者。

此外，2021 年 6 月，普羅米修斯實驗室宣布與 Multiplan 達成協議，以獲得專門的胃腸道測試。 Prometheus 為改善胃腸道疾病的預後提供了突破性的檢測解決方案。該協議將 Prometheus 的測試服務擴展到最大數量的客戶。

胃腸診斷市場報告亮點

  • 按檢查類型分類，由於對微創手術的需求不斷增加，內視鏡檢查領域在 2024 年佔據最大佔有率。
  • 按技術分類，PCR 由於擁有強大的產品系列和增加的產品發布，將在 2024 年佔據第二位。
  • 由於胃腸道感染的高發病率和人們對胃腸道感染疾病的認知不斷提高，感染疾病應用領域在2024年將佔據最大佔有率。
  • 按測試地點分類，2024 年中心實驗室部分佔最大佔有率。預計照護現場市場將在預測期內實現最快的成長率。
  • 由於市場參與企業增加投資和研究活動活性化，預計亞太地區將在預測期內呈現最快的成長率。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章胃腸診斷市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 胃腸道診斷市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章胃腸診斷市場：按測試類型的估計和趨勢分析

  • 2024 年和 2030 年測試類型市場佔有率
  • 細分儀表板
  • 按測試類型分類的全球胃腸道診斷市場前景
  • 2018-2030年市場規模、預測及趨勢分析
    • 內視鏡檢查
    • 驗血
    • 幽門螺旋桿菌檢測
    • 鈣衛蛋白測試
    • 免疫球蛋白A測試
    • 其他

第5章胃腸診斷市場：技術估算與趨勢分析

  • 2023年及2030年技術市場佔有率
  • 細分儀表板
  • 按技術展望分類的全球胃腸診斷市場
  • 2018-2030年市場規模、預測及趨勢分析
    • PCR
    • 微生物學
    • ELISA
    • 其他

第6章胃腸診斷市場：按應用估計和趨勢分析

  • 2024年及2030年應用市場佔有率
  • 細分儀表板
  • 全球胃腸道診斷市場應用前景展望
  • 2018-2030年市場規模、預測及趨勢分析
    • 感染
    • 發炎性腸道疾病
    • 胃食道逆流症
    • 癌症
    • 其他

第7章胃腸診斷市場：檢測地點估算及趨勢分析

  • 2024 年和 2030 年檢查地點市場佔有率
  • 細分儀表板
  • 按測試地點分類的全球胃腸道診斷市場前景
  • 2018-2030年市場規模、預測及趨勢分析
    • 中心實驗室
    • 照護現場

第8章胃腸診斷市場：區域估計與趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場簡介
  • 2018-2030年市場規模及預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • 2024年主要企業市場佔有率分析
    • BIOMERIEUX
    • F. Hoffmann-La Roche Ltd.
    • Abbott
    • Beckman Coulter, Inc.
    • Siemens Healthineers AG
    • DiaSorin SpA
    • QIAGEN
    • Meridian Bioscience
    • Hologic, Inc.
Product Code: GVR-4-68039-988-6

Gastrointestinal Diagnostics Market Growth & Trends:

The global gastrointestinal diagnostics market size is expected to reach USD 6.56 billion by 2030, registering a CAGR of 4.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising awareness about gastrointestinal disorders and a surge in gastrointestinal disorder testing are the major factors driving the market. Moreover, technological advancements in gastrointestinal infection testing are expected to cater to the market demand. For instance, in May 2022, QIAGEN launched QIAstat-Dx Rise, which is capable of providing results in a span of one hour for multiple diseases.

The increasing trend of a sedentary lifestyle, lack of exercise, unhealthy eating habits, and a higher prevalence of obesity are anticipated to fuel GI diagnostics market growth. According to the CDC, the prevalence of obesity among people in the U.S. is between 30-40%. States such as Alabama, Alaska, and Arizona have the highest prevalence of obesity in the U.S. Obesity is associated with GI diseases such as gastroesophageal reflux disease, diarrhea, gastric cancer, and others. Hence, it is expected to impetus market growth.

Technological advancements associated with gastrointestinal diagnostics for early diagnosis and efficient testing are expected to augment market growth during the forecast period. For instance, in March 2022, Luminex Corporation obtained a CE mark for its NxTAGxMAP GI Pathogen Panel. This test is a detailed multiplex test that detects nucleic acids from the 16 most clinically relevant viral, parasitic, and bacterial pathogens in stool samples. Moreover, the test is capable of providing results on the same day and can run 96 samples at a time.

Moreover, the presence of organizations involved in increasing awareness regarding gastrointestinal disorders is expected to facilitate market expansion. For instance, organizations such as the Gastrointestinal Society (Canadian Society of Intestinal Research) and the International Foundation for Gastrointestinal Disorders are actively involved in promoting gastrointestinal health and broadening the understanding of GI disorders, thereby augmenting market growth.

Furthermore, various strategic initiatives undertaken by market players to strengthen their product portfolio and expand global footprints are likely to provide lucrative growth opportunities for the market. For instance, in November 2021, The Life Raft Group and Bayer Pharmaceuticals announced a research collaboration for broadening access to genomic testing for GI stromal tumor patients. The aim of this collaboration is to advance precision medicine and improve genetic testing to identify patients in the U.S.

In addition, in June 2021, Prometheus Laboratories, Inc. announced an agreement with MultiPlan for accessing specialized gastrointestinal testing. Prometheus offered its breakthrough testing solutions to improve the outcome of GI disorders. This agreement has allowed the testing service of Prometheus to reach the maximum number of customers.

Gastrointestinal Diagnostics Market Report Highlights:

  • On the basis of test type, the endoscopy segment held the largest share in 2024 owing to rising demand for minimally invasive procedures
  • Based on technology, the PCR accounted for the second-largest share in 2024 due to the availability of a robust product portfolio and rising product launches
  • The infection application segment held the largest share in 2024 owing to the higher incidence of GI infections and the surge in awareness
  • On the basis of test location, the central laboratories segment held the largest share in 2024. The point-of-care segment is anticipated to register the fastest growth rate throughout the forecast period
  • Asia Pacific is expected to exhibit the fastest growth rate over the forecast period due to the rising investments by market players and increasing research activities in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Test Type
    • 1.2.2. Technology
    • 1.2.3. Application
    • 1.2.4. Test Location
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Test type outlook
    • 2.2.2. Technology outlook
    • 2.2.3. Application outlook
    • 2.2.4. Test location outlook
  • 2.3. Competitive Insights

Chapter 3. Gastrointestinal Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. High prevalence of substance abuse
      • 3.2.1.2. Increase in prevalence of Gastrointestinal disorders
      • 3.2.1.3. Technological advancements pertaining to GI diagnostics
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Presence of stringent rules and regulations for GI diagnostic procedures
  • 3.3. Gastrointestinal Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Gastrointestinal Diagnostics Market: Test Type Estimates & Trend Analysis

  • 4.1. Test Type Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Gastrointestinal Diagnostics Market by Test Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Endoscopy
      • 4.4.1.1. Endoscopy market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Blood Test
      • 4.4.2.1. Blood Test market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. H. Pylori Test
      • 4.4.3.1. H. Pylori Test market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Calprotectin Test
      • 4.4.4.1. Calprotectin Test market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Immunoglobulin A Test
      • 4.4.5.1. Immunoglobulin A Test market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Gastrointestinal Diagnostics Market: Technology Estimates & Trend Analysis

  • 5.1. Technology Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Gastrointestinal Diagnostics Market by Technology Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. PCR
      • 5.4.1.1. PCR market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Microbiology
      • 5.4.2.1. Microbiology market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. ELISA
      • 5.4.3.1. ELISA market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Gastrointestinal Diagnostics Market: Application Estimates & Trend Analysis

  • 6.1. Application Market Share, 2024 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Gastrointestinal Diagnostics Market by Application Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Infection
      • 6.4.1.1. Infection market estimates and forecasts 2018 to 2030 (USD million)
    • 6.4.2. Inflammatory Bowel Disease
      • 6.4.2.1. Inflammatory Bowel Disease market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Gastroesophageal Reflux Disease
      • 6.4.3.1. Gastroesophageal reflux disease market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Cancer
      • 6.4.4.1. Cancer market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Others
      • 6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Gastrointestinal Diagnostics Market: Test Location Estimates & Trend Analysis

  • 7.1. Test Location Market Share, 2024 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Gastrointestinal Diagnostics Market by Test Location Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.4.1. Central Laboratories
      • 7.4.1.1. Central Laboratories market estimates and forecasts 2018 to 2030 (USD million)
    • 7.4.2. Point-of-Care
      • 7.4.2.1. Point-of-Care market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Gastrointestinal Diagnostics Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 8.5. North America
    • 8.5.1. U.S.
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. Canada
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million
  • 8.6. Europe
    • 8.6.1. UK
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Germany
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. France
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. Italy
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework/ reimbursement structure
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Spain
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework/ reimbursement structure
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. Norway
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework/ reimbursement structure
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.7. Sweden
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework/ reimbursement structure
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.8. Denmark
      • 8.6.8.1. Key country dynamics
      • 8.6.8.2. Regulatory framework/ reimbursement structure
      • 8.6.8.3. Competitive scenario
      • 8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.1. Japan
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. China
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. India
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. Australia
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.5. South Korea
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework/ reimbursement structure
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.6. Thailand
      • 8.7.6.1. Key country dynamics
      • 8.7.6.2. Regulatory framework/ reimbursement structure
      • 8.7.6.3. Competitive scenario
      • 8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Brazil
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework/ reimbursement structure
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. Argentina
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework/ reimbursement structure
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9. MEA
    • 8.9.1. South Africa
      • 8.9.1.1. Key country dynamics
      • 8.9.1.2. Regulatory framework/ reimbursement structure
      • 8.9.1.3. Competitive scenario
      • 8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.2. Saudi Arabia
      • 8.9.2.1. Key country dynamics
      • 8.9.2.2. Regulatory framework/ reimbursement structure
      • 8.9.2.3. Competitive scenario
      • 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.3. UAE
      • 8.9.3.1. Key country dynamics
      • 8.9.3.2. Regulatory framework/ reimbursement structure
      • 8.9.3.3. Competitive scenario
      • 8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.4. Kuwait
      • 8.9.4.1. Key country dynamics
      • 8.9.4.2. Regulatory framework/ reimbursement structure
      • 8.9.4.3. Competitive scenario
      • 8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. Key company market share analysis, 2024
    • 9.3.2. BIOMERIEUX
      • 9.3.2.1. Company overview
      • 9.3.2.2. Financial performance
      • 9.3.2.3. Product benchmarking
      • 9.3.2.4. Strategic initiatives
    • 9.3.3. F. Hoffmann-La Roche Ltd.
      • 9.3.3.1. Company overview
      • 9.3.3.2. Financial performance
      • 9.3.3.3. Product benchmarking
      • 9.3.3.4. Strategic initiatives
    • 9.3.4. Abbott
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Beckman Coulter, Inc.
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Siemens Healthineers AG
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. DiaSorin S.p.A
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. QIAGEN
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. Meridian Bioscience
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Hologic, Inc.
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of abbreviation
  • Table 3 North America gastrointestinal diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 5 North America gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 6 North America gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 7 North America gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 8 U.S. gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 9 U.S. gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 10 U.S. gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 11 U.S. gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 12 Canada gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 13 Canada gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 14 Canada gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 16 Mexico gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 17 Mexico gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Mexico gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 19 Mexico gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 20 Europe gastrointestinal diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 22 Europe gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 23 Europe gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 24 Europe gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 25 Germany gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 26 Germany gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Germany gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 28 Germany gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 29 UK gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 30 UK gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 31 UK gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 32 UK gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 33 France gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 34 France gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 35 France gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 36 France gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 37 Italy gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 38 Italy gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 39 Italy gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 40 Italy gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 41 Spain gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 42 Spain gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Spain gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 44 Spain gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 45 Denmark gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 46 Denmark gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 47 Denmark gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 48 Denmark gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 49 Sweden gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 50 Sweden gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 51 Sweden gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 52 Sweden gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 53 Norway gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 54 Norway gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 55 Norway gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 56 Norway gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific gastrointestinal diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 62 China gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 63 China gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 64 China gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 65 China gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 66 Japan gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 67 Japan gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Japan gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 69 Japan gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 70 India gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 71 India gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 72 India gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 73 India gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 74 South Korea gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 75 South Korea gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 76 South Korea gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 77 South Korea gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 78 Australia gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 79 Australia gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 80 Australia gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 81 Australia gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 82 Thailand gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 83 Thailand gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 84 Thailand gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 85 Thailand gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 86 Latin America gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 87 Latin America gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 88 Latin America gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 89 Latin America gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 90 Brazil gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 91 Brazil gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 92 Brazil gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 93 Brazil gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 94 Argentina gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 95 Argentina gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 96 Argentina gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 97 Argentina gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 98 MEA gastrointestinal diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 99 MEA gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 100 MEA gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 101 MEA gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 102 MEA gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 103 South Africa gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 104 South Africa gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 105 South Africa gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 106 South Africa gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 111 UAE gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 112 UAE gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 113 UAE gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 114 UAE gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 115 Kuwait gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 116 Kuwait gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 117 Kuwait gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 118 Kuwait gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Market research approaches
  • Fig. 4 Value chain-based sizing & forecasting
  • Fig. 5 Market formulation & validation
  • Fig. 6 Gastrointestinal Diagnostics market segmentation
  • Fig. 7 Market driver analysis (current & future impact)
  • Fig. 8 Market restraint analysis (current & future impact)
  • Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 10 Porter's five forces analysis
  • Fig. 11 Gastrointestinal Diagnostics market: Test Type movement analysis
  • Fig. 12 Endoscopy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 13 Blood test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 H. pylori test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Calprotectin test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Immunoglobulin A test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Gastrointestinal Diagnostics market: Technology movement Analysis
  • Fig. 19 ELISA market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 PCR market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Microbiology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Gastrointestinal Diagnostics market: Application movement analysis
  • Fig. 24 Infection market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Inflammatory Bowel Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Gastroesophageal Reflux Disease (GERD) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Gastrointestinal Diagnostics market: Test Location movement analysis
  • Fig. 30 Central laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Point-of-Care market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Market share of key market players- gastrointestinal diagnostics market